Elite Pharmaceuticals Inc  

(Public, OTCMKTS:ELTP)   Watch this stock  
Find more results for OTC:ELTP
+0.005 (3.08%)
Delayed:   2:27PM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.16 - 0.17
52 week 0.11 - 0.44
Open 0.17
Vol / Avg. 215,430.00/1.02M
Mkt cap 121.00M
P/E     -
Div/yield     -
EPS -0.03
Shares 733.72M
Beta 0.06
Inst. own 0%
Nov 7, 2016
Q2 2017 Elite Pharmaceuticals Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Aug 11, 2016
Q1 2017 Elite Pharmaceuticals Inc Earnings Call
Aug 9, 2016
Q1 2017 Elite Pharmaceuticals Inc Earnings Release

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin 33.44% -5.46%
Operating margin -37.83% -66.54%
EBITD margin - -61.21%
Return on average assets 13.56% -2.37%
Return on average equity - -
Employees 35 -
CDP Score - -


165 Ludlow Ave
NORTHVALE, NJ 07647-2305
United States - Map
+1-201-7502646 (Phone)
+1-201-7502755 (Fax)

Website links


Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company develops and manufactures generic products, products using controlled-release drug technology, products utilizing abuse deterrent technologies, and it develops and markets generic controlled-release and abuse deterrent pharmaceutical products. Its segments include Abbreviated New Drug Applications (ANDA's) for generic products and New Drug Applications (NDA's) for branded products. The Company owns approximately six different approved ANDA's. The Company's product, SequestOx, is an immediate-release Oxycodone Hydrochloride containing sequestered Naltrexone, which incorporates five milligram, 10 milligram, 15 milligram, 20 milligram and 30 milligram doses of oxycodone into capsules. SequestOx is used for the management of moderate to severe pain where the use of an opioid analgesic is appropriate.

Officers and directors

Nasrat Hakim Chairman of the Board, President, Chief Executive Officer
Age: 54
Carter Julian Ward CPA Chief Financial Officer, Treasurer, Secretary
Age: 51
Douglas Plassche Executive Vice President - Operations
Age: 51
Davis S. Caskey Director
Age: 65
Eugene M. Pfeifer Director
Barry H. Dash Ph.D. Independent Director
Age: 84
Jeffrey A. Whitnell CPA Independent Director
Age: 59